Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review
Breast cancer (BC) is the most common cancer worldwide. Chemotherapy (CT) is essential for the treatment of BC, but is often accompanied by several side effects, including taste alterations, due to different mechanisms. Although dysgeusia is usually underestimated by clinicians, it is considered ver...
Main Authors: | Marianna Pellegrini, Fabio Dario Merlo, Elena Agnello, Taira Monge, Andrea Devecchi, Valentina Casalone, Filippo Montemurro, Ezio Ghigo, Anna Sapino, Simona Bo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/1/226 |
Similar Items
-
Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review
by: Ana Sofia Spencer, et al.
Published: (2021-11-01) -
Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan
by: Wang-Huei Sheng, et al.
Published: (2021-01-01) -
Taste and Smell Disorders in Cancer Treatment: Results from an Integrative Rapid Systematic Review
by: Tania Buttiron Webber, et al.
Published: (2023-01-01) -
Management of Dysgeusia related to Cancer
by: DURGESHWORI MUNANKARMI
Published: (2017-05-01) -
Symptomatic Characteristics of Hypozincemia Detected in Long COVID Patients
by: Yui Matsuda, et al.
Published: (2023-03-01)